MusclePharm to Release 3rd Quarter Earnings and Host Conference Call on November 15th
November 08 2013 - 8:00AM
Marketwired
MusclePharm to Release 3rd Quarter Earnings and Host Conference
Call on November 15th
DENVER, CO--(Marketwired - Nov 8, 2013) - MusclePharm
Corporation (OTCQB: MSLP), a leading international, award-winning
sports nutrition company, plans to release its financial results
for the third quarter ended September 30, 2013 prior to the market
open on Friday, November 15, 2013. Subsequently, MusclePharm
management will discuss the results during a conference call to be
broadcast live over the Internet starting at 11:00 am EST.
Conference call particulars are as follows:
- Date - Friday, November 15, 2013
- Time - 11:00 am EST / 8:00 am PST
- Dial in number - (877) 407-9126 or (201) 493-6751 for
international callers
- Both the live Internet broadcast and replay can be
accessed at: http://musclepharm.equisolvewebcast.com/q3-2013
ABOUT MUSCLEPHARM CORPORATION
MusclePharm® is a leading international, award-winning sports
nutrition company offering vitamins and nutritional
supplements which are available in more than 110
countries and available in 15,000+ U.S. retail outlets, including
Costco, Dick's Sporting Goods, 24 Hour Fitness, Bally's, GNC,
Vitamin Shoppe and Vitamin World. The company's brands are
MusclePharm®, Arnold Schwarzenegger Series™, and FitMiss™. The
comprehensive lines of clinically-proven, safe and effective
nutritional supplements are developed through a six-stage research
process that utilizes the expertise of leading nutritional
scientists, doctors and universities. For more information,
visit www.musclepharmcorp.com. Follow the company at
http://www.facebook.com/MusclePharm and
www.Twitter.com/MusclePharm.
FORWARD-LOOKING STATEMENTS
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities and Exchange Act of 1934, as
amended. Statements that are not a description of historical facts
constitute forward-looking statements and may often, but not
always, be identified by the use of such words as "expects",
"anticipates", "intends", "estimates", "plans", "potential",
"possible", "probable", "believes", "seeks", "may", "will",
"should", "could" or the negative of such terms or other similar
expressions. Actual results may differ materially from those set
forth in this release due to the risks and uncertainties inherent
in the Company's business. More detailed information about the
Company and the risk factors that may affect the realization of
forward-looking statements is set forth in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2012,
the Company's Quarter Reports on Form 10-Q and other filings
submitted by the Company to the SEC, copies of which may be
obtained from the SEC's website at www.sec.gov. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. All
forward-looking statements are qualified in their entirety by this
cautionary statement and the Company undertakes no obligation to
revise or update this release to reflect events or circumstances
after the date hereof.
MusclePharm Investor Contact: The Del Mar Consulting Group, Inc.
Robert B. Prag President Telephone: 858-794-9500 Email: Email
Contact or Alex Partners, LLC Scott Wilfong President Telephone:
425-242-0891 Email: Email Contact
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Jul 2023 to Jul 2024